Pet Pharm Biotech Co., Ltd. (7762)
TWSE
Closed
Aug 25, 2026
Day's Range
56.1052 wk Range
44.00Overview - 7762 - Pet Pharm Biotech Co., Ltd.
Key Statistics
Valuation
Enterprise Value
2.58B
P/E (Trailing)
‪127.11‬
Price / Sales (TTM)
‪14.96‬
Price / Book
‪2.83‬
EV / EBITDA
‪67.64‬
Profitability
Profit Margin
‪11.25%‬
Operating Margin
‪8.50%‬
Return on Assets
‪0.87%‬
Return on Equity
‪2.79%‬
Ownership
Shares Outstanding
57.23M
Float
38.69M
Price stats
Beta
‪0.62‬
50-Day Avg
‪50.50‬
200-Day Avg
‪57.20‬
Dividends
Payout Ratio
‪19.45%‬
Frequency
Annual
Market Cap - 7762 - Pet Pharm Biotech Co., Ltd.
Peers - 7762 - Pet Pharm Biotech Co., Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on TWSE.
- 7762TWSEPet Pharm Biotech Co., Ltd.3.36BMarket Cap-19.34%52-week change127.11P/E (Trailing)‪11.25%‬Profit Margin
- 6130TWSEShangya Technology Co., Ltd.1.37BMarket Cap-39.14%52-week change22.22P/E (Trailing)‪-47.40%‬Profit Margin
- 4102TWSEYung Zip Chemical Ind. Co., Ltd.779.68MMarket Cap-33.15%52-week change24.06P/E (Trailing)‪-2.37%‬Profit Margin
Profile Summary - 7762 - Pet Pharm Biotech Co., Ltd.
About
Pet Pharm Biotech Co., Ltd. is a biotechnology company specializing in the development, production, and sale of pharmaceutical products with a focus on molecular imaging medicines and radiopharmaceuticals. Founded in 2011 and headquartered in New Taipei City, Taiwan, the company employs specialized manufacturing…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
